Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bukrinsky

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Clinical Chemistry|January 3, 2024
An Old Drug Learning New Tricks: A REPRIEVE for Cardiovascular Disease in HIV InfectionDmitri Sviridov, Michael Bukrinsky
Molecular Medicine (Cambridge, Mass.)|June 14, 2012
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationMudit Tyagi, Michael Bukrinsky
Expert Review of Anti-Infective Therapy|March 11, 2005
Nuclear translocation as a novel target for anti-HIV drugsOmar Haffar, Michael Bukrinsky
Future Virology|May 10, 2013
Reverse transcription complex: the key player of the early phase of HIV replicationSergey Iordanskiy, Michael Bukrinsky
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 9, 2023
Neuro-HIV-New insights into pathogenesis and emerging therapeutic targetsDmitri Sviridov, Michael Bukrinsky
Virology|June 11, 2013
Nature, nurture and HIV: The effect of producer cell on viral physiologySergey Iordanskiy, Steven Santos, Michael Bukrinsky
Biochimica Et Biophysica Acta|August 20, 2010
Strategies to inhibit viral protein nuclear import: HIV-1 as a targetAviad Levin, Abraham Loyter, Michael Bukrinsky
Immunology|February 16, 2006
Dealing with the family: CD147 interactions with cyclophilinsVyacheslav Yurchenko, Stephanie Constant, Michael Bukrinsky
Current HIV Research|March 12, 2009
HIV-1 viral protein R (Vpr) and its interactions with host cellGe Li, Michael Bukrinsky, Richard Y Zhao
Current HIV Research|March 25, 2016
Mechanisms of HIV Transcriptional Regulation by Drugs of AbuseMudit Tyagi, Michael Bukrinsky, Gary L Simon
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|January 3, 2024
An Old Drug Learning New Tricks: A REPRIEVE for Cardiovascular Disease in HIV InfectionDmitri Sviridov, Michael Bukrinsky
Molecular Medicine (Cambridge, Mass.)|June 14, 2012
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationMudit Tyagi, Michael Bukrinsky
Expert Review of Anti-Infective Therapy|March 11, 2005
Nuclear translocation as a novel target for anti-HIV drugsOmar Haffar, Michael Bukrinsky
Future Virology|May 10, 2013
Reverse transcription complex: the key player of the early phase of HIV replicationSergey Iordanskiy, Michael Bukrinsky
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 9, 2023
Neuro-HIV-New insights into pathogenesis and emerging therapeutic targetsDmitri Sviridov, Michael Bukrinsky
Virology|June 11, 2013
Nature, nurture and HIV: The effect of producer cell on viral physiologySergey Iordanskiy, Steven Santos, Michael Bukrinsky
Biochimica Et Biophysica Acta|August 20, 2010
Strategies to inhibit viral protein nuclear import: HIV-1 as a targetAviad Levin, Abraham Loyter, Michael Bukrinsky
Immunology|February 16, 2006
Dealing with the family: CD147 interactions with cyclophilinsVyacheslav Yurchenko, Stephanie Constant, Michael Bukrinsky
Current HIV Research|March 12, 2009
HIV-1 viral protein R (Vpr) and its interactions with host cellGe Li, Michael Bukrinsky, Richard Y Zhao
Current HIV Research|March 25, 2016
Mechanisms of HIV Transcriptional Regulation by Drugs of AbuseMudit Tyagi, Michael Bukrinsky, Gary L Simon
Pageof 11